|
US4196265A
(en)
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
US4172124A
(en)
|
1978-04-28 |
1979-10-23 |
The Wistar Institute |
Method of producing tumor antibodies
|
|
US4608337A
(en)
|
1980-11-07 |
1986-08-26 |
The Wistar Institute |
Human hybridomas and the production of human monoclonal antibodies by human hybridomas
|
|
US4701409A
(en)
|
1984-11-15 |
1987-10-20 |
The Wistar Institute |
Detection of B-cell neoplasms
|
|
US4693975A
(en)
|
1984-11-20 |
1987-09-15 |
The Wistar Institute |
Human hybridroma fusion partner for production of human monoclonal antibodies
|
|
US5015568A
(en)
|
1986-07-09 |
1991-05-14 |
The Wistar Institute |
Diagnostic methods for detecting lymphomas in humans
|
|
US5202429A
(en)
|
1986-07-09 |
1993-04-13 |
The Wistar Institute |
DNA molecules having human BCL-2 gene sequences
|
|
US5198338A
(en)
|
1989-05-31 |
1993-03-30 |
Temple University |
Molecular probing for human t-cell leukemia and lymphoma
|
|
US5149628A
(en)
|
1989-11-15 |
1992-09-22 |
Temple University |
Methods for detecting bcl-3 gene in human leukemias
|
|
US5633135A
(en)
|
1991-12-11 |
1997-05-27 |
Thomas Jefferson University |
Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities
|
|
WO1993012136A1
(en)
|
1991-12-11 |
1993-06-24 |
Thomas Jefferson University |
Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region
|
|
US6040140A
(en)
|
1991-12-11 |
2000-03-21 |
Thomas Jefferson University |
Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities
|
|
US5674682A
(en)
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
|
WO1994010343A1
(en)
|
1992-10-29 |
1994-05-11 |
Thomas Jefferson University |
Methods of detecting micrometastasis of prostate cancer
|
|
US7175995B1
(en)
|
1994-10-27 |
2007-02-13 |
Thomas Jefferson University |
TCL-1 protein and related methods
|
|
US5985598A
(en)
|
1994-10-27 |
1999-11-16 |
Thomas Jefferson University |
TCL-1 gene and protein and related methods and compositions
|
|
US5695944A
(en)
|
1995-05-05 |
1997-12-09 |
Thomas Jefferson University |
Modulation of bcl-2 phosphorylation
|
|
US5567586A
(en)
|
1995-05-18 |
1996-10-22 |
Thomas Jefferson University |
Methods of indentifying solid tumors with chromosome abnormalities in the ALL-1 region
|
|
US6242212B1
(en)
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
|
US5928884A
(en)
|
1996-02-09 |
1999-07-27 |
Croce; Carlo M. |
FHIT proteins and nucleic acids and methods based thereon
|
|
WO1998035707A1
(en)
|
1997-02-18 |
1998-08-20 |
Thomas Jefferson University |
Compositions that bind to pancreatic cancer cells and methods of using the same
|
|
AU6951098A
(en)
|
1997-04-04 |
1998-10-30 |
The Texas A & M University System |
Noninvasive detection of colonic biomarkers using fecal messenger rna
|
|
CA2335315A1
(en)
|
1998-07-20 |
2000-01-27 |
Thomas Jefferson University |
Nitrilase homologs
|
|
AU5128999A
(en)
|
1998-07-24 |
2000-02-14 |
Yeda Research And Development Co. Ltd. |
Prevention of metastasis with 5-aza-2'-deoxycytidine
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
WO2000055169A1
(en)
|
1999-03-15 |
2000-09-21 |
Thomas Jefferson University |
TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
|
|
US6579857B1
(en)
|
1999-06-11 |
2003-06-17 |
Evanston Northwestern Healthcare Research Institute |
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
|
|
US7163801B2
(en)
|
1999-09-01 |
2007-01-16 |
The Burnham Institute |
Methods for determining the prognosis for cancer patients using tucan
|
|
US6891031B2
(en)
|
2000-02-18 |
2005-05-10 |
The Regents Of The University Of California |
Coordinate cytokine regulatory sequences
|
|
US20010026796A1
(en)
|
2000-03-14 |
2001-10-04 |
Croce Carlo M. |
TCL1 enhances Akt kinase activity and mediates its nuclear translocation
|
|
JP2004516002A
(ja)
|
2000-04-11 |
2004-06-03 |
トーマス・ジェファーソン・ユニバーシティー |
Ｆｈｉｔ欠損マウスにおけるミュア−トール様症候群
|
|
WO2001087958A2
(en)
|
2000-05-16 |
2001-11-22 |
Thomas Jefferson University |
CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS
|
|
US7060811B2
(en)
|
2000-10-13 |
2006-06-13 |
Board Of Regents, The University Of Texas System |
WWOX: a tumor suppressor gene mutated in multiple cancers
|
|
US20040033502A1
(en)
|
2001-03-28 |
2004-02-19 |
Amanda Williams |
Gene expression profiles in esophageal tissue
|
|
US20050176025A1
(en)
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
|
|
EP2428568B1
(en)
|
2001-09-28 |
2018-04-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
|
US7371736B2
(en)
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
|
GB0128898D0
(en)
|
2001-12-03 |
2002-01-23 |
Biotech Res Ventures Pte Ltd |
Materials and methods relating to the stabilization and activation of a tumour suppressor protein
|
|
IL163711A0
(en)
|
2002-03-08 |
2005-12-18 |
Eisai Co Ltd |
Macrocyclic compounds useful as pharmaceuticals
|
|
US20060084059A1
(en)
|
2002-04-08 |
2006-04-20 |
Tai-Tung Yip |
Serum biomarkers in hepatocellular carcinoma
|
|
EP1499182B1
(en)
|
2002-04-29 |
2009-10-28 |
Thomas Jefferson University |
Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
|
|
AU2003273542A1
(en)
|
2002-05-31 |
2003-12-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of identifying and isolating stem cells and cancer stem cells
|
|
US20050260639A1
(en)
|
2002-09-30 |
2005-11-24 |
Oncotherapy Science, Inc. |
Method for diagnosing pancreatic cancer
|
|
US20050266443A1
(en)
|
2002-10-11 |
2005-12-01 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
|
CA2501602A1
(en)
|
2002-10-11 |
2004-04-22 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
|
AU2003291433B2
(en)
|
2002-11-13 |
2008-05-22 |
Thomas Jefferson University |
Compositions and methods for cancer diagnosis and therapy
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
WO2004071464A2
(en)
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University School Of Medicine |
Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
|
|
WO2004079013A1
(en)
|
2003-03-03 |
2004-09-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
|
|
US7183384B2
(en)
|
2003-03-06 |
2007-02-27 |
A & G Pharmaceutical, Inc. |
Monoclonal antibody 7H11 reactive with human cancer
|
|
AU2003286741A1
(en)
|
2003-05-02 |
2004-11-26 |
Thomas Jefferson University |
Methods and compositions for diagnosis and therapy of parkin-associated disorders
|
|
WO2006031210A1
(en)
|
2003-05-29 |
2006-03-23 |
Board Of Regents, The University Of Texas Systems |
Jabi as a prognostic marker and a therapeutic target for human cancer
|
|
ATE420160T1
(de)
|
2003-06-18 |
2009-01-15 |
Genelux Corp |
Modifizierte rekombinante vacciniaviren, verwendungen davon
|
|
CA2533701A1
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
US20050037362A1
(en)
|
2003-08-11 |
2005-02-17 |
Eppendorf Array Technologies, S.A. |
Detection and quantification of siRNA on microarrays
|
|
US8412541B2
(en)
|
2003-08-14 |
2013-04-02 |
Edda Technology, Inc. |
Method and system for intelligent qualitative and quantitative analysis for medical diagnosis
|
|
WO2005020795A2
(en)
|
2003-08-25 |
2005-03-10 |
The Johns Hopkins University |
Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differntial gene expression analysis
|
|
CN1882702A
(zh)
*
|
2003-09-22 |
2006-12-20 |
罗斯塔英法美蒂克斯有限责任公司 |
用rna干扰进行的协同致死筛选
|
|
CA2539651A1
(en)
|
2003-09-22 |
2005-04-07 |
Rosetta Inpharmatics Llc |
Synthetic lethal screen using rna interference
|
|
WO2005028675A2
(en)
|
2003-09-24 |
2005-03-31 |
Oncotherapy Science, Inc. |
Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc)
|
|
US20050186589A1
(en)
|
2003-11-07 |
2005-08-25 |
University Of Massachusetts |
Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi
|
|
US20050164252A1
(en)
|
2003-12-04 |
2005-07-28 |
Yeung Wah Hin A. |
Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell
|
|
CA2550447A1
(en)
|
2003-12-19 |
2005-07-07 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
|
JP4120002B2
(ja)
*
|
2004-01-07 |
2008-07-16 |
愛知県 |
ｍｉＲＮＡを用いた癌の予後判定方法、癌の遺伝子治療ベクター及び癌治療用医薬組成物
|
|
WO2005078139A2
(en)
|
2004-02-09 |
2005-08-25 |
Thomas Jefferson University |
DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
|
|
WO2005078096A2
(en)
|
2004-02-09 |
2005-08-25 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
WO2005079397A2
(en)
|
2004-02-13 |
2005-09-01 |
Rockefeller University |
Anti-microrna oligonucleotide molecules
|
|
AU2005214286A1
(en)
|
2004-02-23 |
2005-09-01 |
Erasmus University Medical Center Rotterdam |
Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling
|
|
US7365058B2
(en)
|
2004-04-13 |
2008-04-29 |
The Rockefeller University |
MicroRNA and methods for inhibiting same
|
|
KR20070004957A
(ko)
|
2004-04-20 |
2007-01-09 |
제나코 바이오메디컬 프로덕츠, 인코포레이티드 |
ｎｃＲＮＡ 검출 방법
|
|
WO2005111211A2
(en)
|
2004-05-14 |
2005-11-24 |
Rosetta Genomics Ltd. |
Micronas and uses thereof
|
|
EP2290071B1
(en)
|
2004-05-28 |
2014-12-31 |
Asuragen, Inc. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
US20060037088A1
(en)
|
2004-08-13 |
2006-02-16 |
Shulin Li |
Gene expression levels as predictors of chemoradiation response of cancer
|
|
US7893034B2
(en)
|
2004-09-02 |
2011-02-22 |
Yale University |
Regulation of oncogenes by microRNAs
|
|
US7592441B2
(en)
|
2004-10-04 |
2009-09-22 |
Rosetta Genomics Ltd |
Liver cancer-related nucleic acids
|
|
US7642348B2
(en)
|
2004-10-04 |
2010-01-05 |
Rosetta Genomics Ltd |
Prostate cancer-related nucleic acids
|
|
FR2877350B1
(fr)
|
2004-11-03 |
2010-08-27 |
Centre Nat Rech Scient |
IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE
|
|
AU2005333165B2
(en)
|
2004-11-12 |
2012-07-19 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
|
WO2008073922A2
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Functions and targets of let-7 micro rnas
|
|
US7361752B2
(en)
|
2004-12-14 |
2008-04-22 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of MLL-AF4 and uses thereof
|
|
WO2006066240A2
(en)
*
|
2004-12-17 |
2006-06-22 |
Veridex Llc |
Methods for assessing patients with acute myeloid leukemia
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
WO2006069584A2
(en)
|
2004-12-29 |
2006-07-06 |
Exiqon A/S |
NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
US20090123912A1
(en)
|
2005-01-25 |
2009-05-14 |
Rosetta Inpharmatics Llc |
Methods for quantitating small RNA molecules
|
|
US20070065840A1
(en)
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
|
GB2425311A
(en)
|
2005-04-15 |
2006-10-25 |
Ist Superiore Sanita |
Micro RNA against kit protein
|
|
US8247543B2
(en)
|
2005-04-29 |
2012-08-21 |
The Rockefeller University |
Human microRNAs and methods for inhibiting same
|
|
US20090209621A1
(en)
|
2005-06-03 |
2009-08-20 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
|
US20070065844A1
(en)
|
2005-06-08 |
2007-03-22 |
Massachusetts Institute Of Technology |
Solution-based methods for RNA expression profiling
|
|
US20060292616A1
(en)
|
2005-06-23 |
2006-12-28 |
U.S. Genomics, Inc. |
Single molecule miRNA-based disease diagnostic methods
|
|
CN102533966B
(zh)
|
2005-08-01 |
2014-03-12 |
俄亥俄州立大学研究基金会 |
用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
|
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
EP1919512B1
(en)
|
2005-08-10 |
2014-11-12 |
Alnylam Pharmaceuticals Inc. |
Chemically modified oligonucleotides for use in modulating micro rna and uses thereof
|
|
CA2845251A1
(en)
|
2005-09-12 |
2007-03-22 |
The Ohio State University Research Foundation |
Compositions for the therapy of bcl2-associated cancers and methods of preparation thereof
|
|
EP1940456A4
(en)
|
2005-10-05 |
2009-10-21 |
Univ Ohio State Res Found |
WWOX GENE, VECTORS COMPRISING THE SAME, AND USES THEREOF IN THE TREATMENT OF CANCER
|
|
US7390792B2
(en)
|
2005-12-15 |
2008-06-24 |
Board Of Regents, The University Of Texas System |
MicroRNA1 therapies
|
|
EP2591794A1
(en)
|
2006-01-05 |
2013-05-15 |
The Ohio State University Research Foundation |
MicroRNA expressions abnormalities in pancreatic endocrine and acinar tumors
|
|
EP2514434B1
(en)
|
2006-01-05 |
2015-10-21 |
The Ohio State University Research Foundation |
MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer
|
|
EP2479286B1
(en)
|
2006-01-05 |
2013-11-13 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
US20090007281A1
(en)
|
2006-01-13 |
2009-01-01 |
Battelle Memorial Institute |
Animal Model for Assessing Copd-Related Diseases
|
|
CA2646051A1
(en)
|
2006-03-20 |
2007-09-27 |
Carlo M. Croce |
Microrna fingerprints during human megakaryocytopoiesis
|
|
US20090324618A1
(en)
|
2006-03-24 |
2009-12-31 |
Armstrong Scott A |
Novel signature self renewal gene expression programs
|
|
US20100004320A1
(en)
|
2006-04-03 |
2010-01-07 |
Santaris Pharma A/S |
Pharmaceutical Composition
|
|
EP2023944A4
(en)
|
2006-04-24 |
2011-10-05 |
Univ Ohio State Res Found |
PRE-B CELL PROLIFERATION AND HIGH-GRADE LYMPHOBLASTIC LEUKEMIA / LYMPHOMA IN TRANSGENIC MICE MIR155
|
|
ES2562607T3
(es)
|
2006-07-13 |
2016-03-07 |
The Ohio State University Research Foundation |
MIR-21 para el diagnóstico de adenocarcinoma de colon con mal pronóstico de supervivencia
|
|
ZA200901224B
(en)
|
2006-08-30 |
2010-05-26 |
Univ Michigan |
New small molecule inhibitors of MDM2 the uses thereof
|
|
US20080193943A1
(en)
|
2006-09-05 |
2008-08-14 |
Abbott Laboratories |
Companion diagnostic assays for cancer therapy
|
|
CA2663962A1
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
|
|
AU2007299828C1
(en)
|
2006-09-19 |
2014-07-17 |
Interpace Diagnostics, Llc |
MicroRNAs differentially expressed in pancreatic diseases and uses thereof
|
|
CN101535505A
(zh)
|
2006-09-19 |
2009-09-16 |
俄亥俄州立大学研究基金会 |
慢性淋巴细胞性白血病(CLL)中受miR-29和miR-181调控的TCL1的表达
|
|
WO2008036741A2
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-200 regulated genes and pathways as targets for therapeutic intervention
|
|
AU2007314212B2
(en)
|
2006-11-01 |
2014-05-29 |
The Govt. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services |
MicroRNA expression signature for predicting survival and metastases in Hepatocellular carcinoma
|
|
US8293684B2
(en)
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
|
WO2008070082A2
(en)
|
2006-12-04 |
2008-06-12 |
The Johns Hopkins University |
Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
|
|
AU2007333107A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-21 regulated genes and pathways as targets for therapeutic intervention
|
|
CN101622349A
(zh)
|
2006-12-08 |
2010-01-06 |
奥斯瑞根公司 |
作为治疗性干预靶标的miR-21调节的基因和途径
|
|
CA2671194A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Mir-20 regulated genes and pathways as targets for therapeutic intervention
|
|
CA2671270A1
(en)
|
2006-12-29 |
2008-07-17 |
Asuragen, Inc. |
Mir-16 regulated genes and pathways as targets for therapeutic intervention
|
|
CN103555825B
(zh)
|
2007-01-31 |
2015-09-30 |
俄亥俄州立大学研究基金会 |
用于急性髓细胞白血病(aml)的诊断、预后和治疗的基于微rna的方法和组合物
|
|
US8765702B2
(en)
|
2007-02-27 |
2014-07-01 |
Rosetta Genomics Ltd. |
Composition and methods for modulating cell proliferation and cell death
|
|
JP5331714B2
(ja)
|
2007-03-16 |
2013-10-30 |
コヴァルクス・アーゲー |
タンパク質複合体をターゲティングする薬物候補の直接質量分析
|
|
EP2134874A4
(en)
|
2007-04-10 |
2010-12-22 |
Univ Nat Taiwan |
PROGNOSIS OF SURVIVAL RATE OF PATIENTS AFTER TREATMENT WITH miRNA
|
|
WO2008136971A1
(en)
|
2007-04-30 |
2008-11-13 |
The Ohio State University Research Foundation |
Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
|
|
US20090005336A1
(en)
|
2007-05-08 |
2009-01-01 |
Zhiguo Wang |
Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
|
|
US20090131354A1
(en)
|
2007-05-22 |
2009-05-21 |
Bader Andreas G |
miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
US20090232893A1
(en)
|
2007-05-22 |
2009-09-17 |
Bader Andreas G |
miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
US20090099034A1
(en)
|
2007-06-07 |
2009-04-16 |
Wisconsin Alumni Research Foundation |
Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
|
|
AU2008262252B2
(en)
|
2007-06-08 |
2013-09-12 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells
|
|
CN101801419A
(zh)
|
2007-06-08 |
2010-08-11 |
米尔纳疗法公司 |
作为治疗干预的靶标的miR-34调控的基因和路径
|
|
AU2008266014B2
(en)
|
2007-06-15 |
2013-06-06 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting drosha-mediated microRNA processing
|
|
WO2009018303A2
(en)
|
2007-07-31 |
2009-02-05 |
The Ohio State University Research Foundation |
Methods for reverting methylation by targeting dnmt3a and dnmt3b
|
|
CA2695514A1
(en)
|
2007-08-03 |
2009-02-12 |
The Ohio State University Research Foundation |
Ultraconserved regions encoding ncrnas
|
|
AU2008288806B2
(en)
|
2007-08-22 |
2014-11-27 |
The Ohio State University Research Foundation |
Methods and compositions for inducing deregulation of EphA7 and Erk phosphorylation in human acute leukemias
|
|
US20090061424A1
(en)
|
2007-08-30 |
2009-03-05 |
Sigma-Aldrich Company |
Universal ligation array for analyzing gene expression or genomic variations
|
|
CA2698771A1
(en)
|
2007-09-06 |
2009-03-12 |
The Ohio State University Research Foundation |
Microrna signatures in human ovarian cancer
|
|
CN101861401B
(zh)
|
2007-10-11 |
2014-03-12 |
俄亥俄州立大学研究基金会 |
用于诊断和治疗食管腺癌的方法和组合物
|
|
JP2011504093A
(ja)
|
2007-10-26 |
2011-02-03 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
脆弱性ヒスチジン三連構造（ｆｈｉｔ）相互作用を同定するための方法およびその使用
|
|
US20090123933A1
(en)
|
2007-11-12 |
2009-05-14 |
Wake Forest University Health Sciences |
Microrna biomarkers in lupus
|
|
WO2009064590A2
(en)
|
2007-11-12 |
2009-05-22 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
|
|
EP2225396A4
(en)
|
2007-11-30 |
2011-03-02 |
Univ Ohio State Res Found |
PROFILING AND SCREENING OF MICRO-RNA EXPRESSION IN PERIPHERAL BLOOD IN LUNG CANCER
|
|
US8071562B2
(en)
|
2007-12-01 |
2011-12-06 |
Mirna Therapeutics, Inc. |
MiR-124 regulated genes and pathways as targets for therapeutic intervention
|
|
WO2009086156A2
(en)
|
2007-12-21 |
2009-07-09 |
Asuragen, Inc. |
Mir-10 regulated genes and pathways as targets for therapeutic intervention
|
|
KR101970908B1
(ko)
|
2008-02-01 |
2019-04-19 |
더 제너럴 하스피탈 코포레이션 |
의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
|
|
WO2009100430A2
(en)
|
2008-02-08 |
2009-08-13 |
Asuragen, Inc |
miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
|
|
CN102015027A
(zh)
|
2008-02-28 |
2011-04-13 |
俄亥俄州立大学研究基金会 |
与人慢性淋巴细胞性白血病(ccl)相关的微rna特征和其用途
|
|
EP2250496A4
(en)
|
2008-02-28 |
2011-08-31 |
Univ Ohio State Res Found |
MICRO-RNA SIGNATURES ASSOCIATED WITH CYTOGENETICS AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA (AML) AND USES THEREOF
|
|
US20110034538A1
(en)
|
2008-02-28 |
2011-02-10 |
The Ohio State University Research Foundation |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer
|
|
EP3112477A1
(en)
|
2008-02-28 |
2017-01-04 |
The Ohio State University Research Foundation |
Microrna-based methods and compositions for the diagnosis, prognosis and treatment of prostate related disorders
|
|
WO2009111643A2
(en)
|
2008-03-06 |
2009-09-11 |
Asuragen, Inc. |
Microrna markers for recurrence of colorectal cancer
|
|
EP2271757A2
(en)
|
2008-03-26 |
2011-01-12 |
Asuragen, INC. |
Compositions and methods related to mir-16 and therapy of prostate cancer
|
|
EP2990487A1
(en)
|
2008-05-08 |
2016-03-02 |
Asuragen, INC. |
Compositions and methods related to mirna modulation of neovascularization or angiogenesis
|
|
WO2009149418A2
(en)
|
2008-06-06 |
2009-12-10 |
Asuragen, Inc. |
Novel compositions for the in vivo delivery of rnai agents
|
|
AU2009257410B2
(en)
|
2008-06-11 |
2014-03-06 |
Fudan University |
Use of miR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
|
|
JP2012500389A
(ja)
|
2008-08-12 |
2012-01-05 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
多発性脊髄腫の診断、予後および治療のためのマイクロｒｎａに基づく組成物および方法
|
|
US20110311555A1
(en)
|
2008-11-21 |
2011-12-22 |
The Ohio State University |
Tc11 as a Transcriptional Regulator
|
|
CN102292456A
(zh)
|
2008-12-05 |
2011-12-21 |
俄亥俄州立大学研究基金会 |
用于诊断和治疗卵巢癌的基于microRNA 的方法和组合物
|
|
EP2401405A4
(en)
|
2009-02-26 |
2013-10-16 |
Univ Ohio State Res Found |
MICRO-RNAS FOR NON-SMOKERS AND RELATED MATERIALS AND METHODS
|